Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Numares has commercialized several CE-marked IVD tests on its AXINON platform in Europe and received FDA clearance for its LDL-p Test System. The company’s pipeline includes advanced diagnostic assays targeting cardiovascular risk, kidney function/transplantation outcomes, liver cancer detection, and multiple sclerosis. Clinical studies are ongoing to expand regulatory approvals and validate new indications. Strategic collaborations with Mayo Clinic Laboratories and Oxford University support further clinical validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on numares.